MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, W.
Right arrow Articles by Sealfon, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, W.
Right arrow Articles by Sealfon, S. C.

A reciprocal mutation supports helix 2 and helix 7 proximity in the gonadotropin-releasing hormone receptor

W Zhou, C Flanagan, JA Ballesteros, K Konvicka, JS Davidson, H Weinstein, RP Millar and SC Sealfon

Dr. Arthur M. Fishberg Research Center in Neurobiology, Mount Sinai School of Medicine, New York, New York 10029.

Activation of the pituitary gonadotropin-releasing hormone receptor, a member of the seven-transmembrane G protein-coupled receptor (GPCR) family, triggers a cascade of events leading to gonadotropin release and stimulation of the reproductive system. An unusual feature of this receptor, observed in mice, rats, and humans, is the presence of Asn87 in the second putative transmembrane helix at the location of a highly conserved aspartate in the GPCR family and of Asp318 in the putative seventh transmembrane helix where nearly all other GPCRs have asparagine. The possibility that these residues interact was suggested by this reciprocal pattern and by a three-dimensional model of the gonadotropin-releasing hormone receptor and was investigated by site- directed mutagenesis. Replacing Asn87 in the second transmembrane domain by aspartate eliminated detectable ligand binding. A second mutation, generating the double-mutant receptor Asp87Asn318, recreated the arrangement found in other GPCRs and re-established high affinity agonist and antagonist binding. The restoration of binding by a reciprocal mutation indicates that these two specific residues in helices 2 and 7 are adjacent in space and provides an empirical basis to refine the model of the transmembrane helix bundle of the receptor.

Volume 45, Issue 2, pp. 165-170, 02/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Kniazeff, L. Shi, C. J. Loland, J. A. Javitch, H. Weinstein, and U. Gether
An Intracellular Interaction Network Regulates Conformational Transitions in the Dopamine Transporter
J. Biol. Chem., June 20, 2008; 283(25): 17691 - 17701.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. D. G. Pfleger, A. J. Pawson, and R. P. Millar
Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations
Endocrinology, June 1, 2008; 149(6): 3118 - 3129.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kapur, P. Samaniego, G. A. Thakur, A. Makriyannis, and M. E. Abood
Mapping the Structural Requirements in the CB1 Cannabinoid Receptor Transmembrane Helix II for Signal Transduction
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 341 - 348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-L. Lu, M. Coetsee, C. D. White, and R. P. Millar
Structural Determinants for Ligand-Receptor Conformational Selection in a Peptide G Protein-coupled Receptor
J. Biol. Chem., June 15, 2007; 282(24): 17921 - 17929.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Basu, V. R. Jala, S. Mathis, S. T. Rajagopal, A. Del Prete, P. Maturu, J. O. Trent, and B. Haribabu
Critical Role for Polar Residues in Coupling Leukotriene B4 Binding to Signal Transduction in BLT1
J. Biol. Chem., March 30, 2007; 282(13): 10005 - 10017.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. E. Barran, R. W. Roeske, A. J. Pawson, R. Sellar, M. T. Bowers, K. Morgan, Z.-L. Lu, M. Tsuda, T. Kusakabe, and R. P. Millar
Evolution of Constrained Gonadotropin-releasing Hormone Ligand Conformation and Receptor Selectivity
J. Biol. Chem., November 18, 2005; 280(46): 38569 - 38575.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. R. Hawtin, V. J. Wesley, J. Simms, C. C. H. Argent, K. Latif, and M. Wheatley
The N-Terminal Juxtamembrane Segment of the V1a Vasopressin Receptor Provides Two Independent Epitopes Required for High-Affinity Agonist Binding and Signaling
Mol. Endocrinol., November 1, 2005; 19(11): 2871 - 2881.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Tello, J. E. Rivier, and N. M. Sherwood
Tunicate Gonadotropin-Releasing Hormone (GnRH) Peptides Selectively Activate Ciona intestinalis GnRH Receptors and the Green Monkey Type II GnRH Receptor
Endocrinology, September 1, 2005; 146(9): 4061 - 4073.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zhang, D. P. Hurst, J. Barnett-Norris, P. H. Reggio, and Z.-H. Song
Cysteine 2.59(89) in the Second Transmembrane Domain of Human CB2 Receptor Is Accessible within the Ligand Binding Crevice: Evidence for Possible CB2 Deviation from a Rhodopsin Template
Mol. Pharmacol., July 1, 2005; 68(1): 69 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Urizar, S. Claeysen, X. Deupi, C. Govaerts, S. Costagliola, G. Vassart, and L. Pardo
An Activation Switch in the Rhodopsin Family of G Protein-coupled Receptors: THE THYROTROPIN RECEPTOR
J. Biol. Chem., April 29, 2005; 280(17): 17135 - 17141.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Li, N. M. Nowak, S.-K. Kim, K. A. Jacobson, A. Bagheri, C. Schmidt, and J. Wess
Random Mutagenesis of the M3 Muscarinic Acetylcholine Receptor Expressed in Yeast: IDENTIFICATION OF SECOND-SITE MUTATIONS THAT RESTORE FUNCTION TO A COUPLING-DEFICIENT MUTANT M3 RECEPTOR
J. Biol. Chem., February 18, 2005; 280(7): 5664 - 5675.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley
Gonadotropin-Releasing Hormone Receptors
Endocr. Rev., April 1, 2004; 25(2): 235 - 275.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Karges, W. Karges, M. Mine, L. Ludwig, R. Kuhne, E. Milgrom, and N. de Roux
Mutation Ala171Thr Stabilizes the Gonadotropin-Releasing Hormone Receptor in Its Inactive Conformation, Causing Familial Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1873 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
M. G. Paterlini
Structure Modeling of the Chemokine Receptor CCR5: Implications for Ligand Binding and Selectivity
Biophys. J., December 1, 2002; 83(6): 3012 - 3031.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Prioleau, I. Visiers, B. J. Ebersole, H. Weinstein, and S. C. Sealfon
Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor. IDENTIFICATION OF A NOVEL "LOCKED-ON" PHENOTYPE AND DOUBLE REVERTANT MUTATIONS
J. Biol. Chem., September 20, 2002; 277(39): 36577 - 36584.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. L. Lopez-Rodriguez, B. Vicente, X. Deupi, S. Barrondo, M. Olivella, M. J. Morcillo, B. Behamu, J. A. Ballesteros, J. Salles, and L. Pardo
Design, Synthesis and Pharmacological Evaluation of 5-Hydroxytryptamine1a Receptor Ligands to Explore the Three-Dimensional Structure of the Receptor
Mol. Pharmacol., July 1, 2002; 62(1): 15 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Maya-Nunez, J. A. Janovick, A. Ulloa-Aguirre, D. Soderlund, P. M. Conn, and J. P. Mendez
Molecular Basis of Hypogonadotropic Hypogonadism: Restoration of Mutant (E90K) GnRH Receptor Function by a Deletion at a Distant Site
J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2144 - 2149.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Sugimoto, R. Fujisawa, R. Tanimura, A. L. Lattion, S. Cotecchia, G. Tsujimoto, T. Nagao, and H. Kurose
beta 1-Selective Agonist (-)-1-(3,4-Dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] Differentially Interacts with Key Amino Acids Responsible for beta 1-Selective Binding in Resting and Active States
J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Nie and D. L. Lewis
Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration
J. Neurosci., November 15, 2001; 21(22): 8758 - 8764.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Wang, D. Y. Oh, J. Bogerd, H. S. Choi, R. S. Ahn, J. Y. Seong, and H. B. Kwon
Inhibitory Activity of Alternative Splice Variants of the Bullfrog GnRH Receptor-3 on Wild-Type Receptor Signaling
Endocrinology, September 1, 2001; 142(9): 4015 - 4025.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Ballesteros, L. Shi, and J. A. Javitch
Structural Mimicry in G Protein-Coupled Receptors: Implications of the High-Resolution Structure of Rhodopsin for Structure-Function Analysis of Rhodopsin-Like Receptors
Mol. Pharmacol., July 1, 2001; 60(1): 1 - 19.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Grundker, P. Volker, and G. Emons
Antiproliferative Signaling of Luteinizing Hormone-Releasing Hormone in Human Endometrial and Ovarian Cancer Cells through G Protein {{alpha}}I-Mediated Activation of Phosphotyrosine Phosphatase
Endocrinology, June 1, 2001; 142(6): 2369 - 2380.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. R. Robison, R. B. White, N. Illing, B. E. Troskie, M. Morley, R. P. Millar, and R. D. Fernald
Gonadotropin-Releasing Hormone Receptor in the Teleost Haplochromis burtoni: Structure, Location, and Function
Endocrinology, May 1, 2001; 142(5): 1737 - 1743.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. H. Wilson, H. A. Highfield, and L. E. Limbird
The Role of a Conserved Inter-Transmembrane Domain Interface in Regulating {alpha}2a-Adrenergic Receptor Conformational Stability and Cell-Surface Turnover
Mol. Pharmacol., April 1, 2001; 59(4): 929 - 938.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. Kitanovic, T. Yuen, C. A. Flanagan, B. J. Ebersole, and S. C. Sealfon
Insertional Mutagenesis of the Arginine Cage Domain of the Gonadotropin-Releasing Hormone Receptor
Mol. Endocrinol., March 1, 2001; 15(3): 390 - 397.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. C. Gershengorn and R. Osman
Minireview: Insights into G Protein-Coupled Receptor Function Using Molecular Models
Endocrinology, January 1, 2001; 142(1): 2 - 10.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Wang, J. Bogerd, H. S. Choi, J. Y. Seong, J. M. Soh, S. Y. Chun, M. Blomenröhr, B. E. Troskie, R. P. Millar, W. H. Yu, et al.
Three distinct types of GnRH receptor characterized in the bullfrog
PNAS, December 14, 2000; (2000) 11508498.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
T. Madigou, E. Mañanos-Sanchez, S. Hulshof, I. Anglade, S. Zanuy, and O. Kah
Cloning, Tissue Distribution, and Central Expression of the Gonadotropin-Releasing Hormone Receptor in the Rainbow Trout (Oncorhynchus mykiss)
Biol Reprod, December 1, 2000; 63(6): 1857 - 1866.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M.-L. Kottler, S. Chauvin, N. Lahlou, C. E. Harris, C. J. Johnston, J.-P. Lagarde, P. Bouchard, N. R. Farid, and R. Counis
A New Compound Heterozygous Mutation of the Gonadotropin-Releasing Hormone Receptor (L314X, Q106R) in a Woman with Complete Hypogonadotropic Hypogonadism: Chronic Estrogen Administration Amplifies the Gonadotropin Defect
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3002 - 3008.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. H. Hoffmann, T. t. Laak, R. Kühne, H. Reiländer, and T. Beckers
Residues within Transmembrane Helices 2 and 5 of the Human Gonadotropin-Releasing Hormone Receptor Contribute to Agonist and Antagonist Binding
Mol. Endocrinol., July 1, 2000; 14(7): 1099 - 1115.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
B. E. Troskie, J. P. Hapgood, R. P. Millar, and N. Illing
Complementary Deoxyribonucleic Acid Cloning, Gene Expression, and Ligand Selectivity of a Novel Gonadotropin-Releasing Hormone Receptor Expressed in the Pituitary and Midbrain of Xenopus laevis
Endocrinology, May 1, 2000; 141(5): 1764 - 1771.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Chauvin, A. Bérault, Y. Lerrant, M. Hibert, and R. Counis
Functional Importance of Transmembrane Helix 6 Trp279 and Exoloop 3 Val299 of Rat Gonadotropin-Releasing Hormone Receptor
Mol. Pharmacol., March 1, 2000; 57(3): 625 - 633.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
U. Gether
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Endocr. Rev., February 1, 2000; 21(1): 90 - 113.
[Abstract] [Full Text]


Home page
Protein Eng Des SelHome page
M. Filizola, L. Laakkonen, and G. H. loew
3D modeling, ligand binding and activation studies of the cloned mouse {delta}, {micro} and {kappa} opioid receptors
Protein Eng. Des. Sel., November 1, 1999; 12(11): 927 - 942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Isogaya, Y. Sugimoto, R. Tanimura, R. Tanaka, H. Kikkawa, T. Nagao, and H. Kurose
Binding Pockets of the beta 1- and beta 2-Adrenergic Receptors for Subtype-Selective Agonists
Mol. Pharmacol., November 1, 1999; 56(5): 875 - 885.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. A. Flanagan, W. Zhou, L. Chi, T. Yuen, V. Rodic, D. Robertson, M. Johnson, P. Holland, R. P. Millar, H. Weinstein, et al.
The Functional Microdomain in Transmembrane Helices 2 and 7 Regulates Expression, Activation, and Coupling Pathways of the Gonadotropin-releasing Hormone Receptor
J. Biol. Chem., October 8, 1999; 274(41): 28880 - 28886.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. H. Song, C.-A. Slowey, D. P. Hurst, and P. H. Reggio
The Difference between the CB1 and CB2 Cannabinoid Receptors at Position 5.46 Is Crucial for the Selectivity of WIN55212-2 for CB2
Mol. Pharmacol., October 1, 1999; 56(4): 834 - 840.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. M. Miettinen, J. M. Gripentrog, M. M. Mason, and A. J. Jesaitis
Identification of Putative Sites of Interaction between the Human Formyl Peptide Receptor and G Protein
J. Biol. Chem., September 24, 1999; 274(39): 27934 - 27942.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. P. Roche, S. Bounds, S. Brown, and K. Mackie
A Mutation in the Second Transmembrane Region of the CB1 Receptor Selectively Disrupts G Protein Signaling and Prevents Receptor Internalization
Mol. Pharmacol., September 1, 1999; 56(3): 611 - 618.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Isogaya, Y. Yamagiwa, S. Fujita, Y. Sugimoto, T. Nagao, and H. Kurose
Identification of a Key Amino Acid of the beta 2-Adrenergic Receptor for High Affinity Binding of Salmeterol
Mol. Pharmacol., October 1, 1998; 54(4): 616 - 622.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
U. Gether and B. K. Kobilka
G Protein-coupled Receptors. II. MECHANISM OF AGONIST ACTIVATION
J. Biol. Chem., July 17, 1998; 273(29): 17979 - 17982.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Hadac, D. I. Pinon, Z. Ji, E. L. Holicky, R. M. Henne, T. P. Lybrand, and L. J. Miller
Direct Identification of a Second Distinct Site of Contact between Cholecystokinin and Its Receptor
J. Biol. Chem., May 22, 1998; 273(21): 12988 - 12993.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Q. Tao and M. E. Abood
Mutation of a Highly Conserved Aspartate Residue in the Second Transmembrane Domain of the Cannabinoid Receptors, CB1 and CB2, Disrupts G-Protein Coupling
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 651 - 658.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Ballesteros, S. Kitanovic, F. Guarnieri, P. Davies, B. J. Fromme, K. Konvicka, L. Chi, R. P. Millar, J. S. Davidson, H. Weinstein, et al.
Functional Microdomains in G-protein-coupled Receptors. THE CONSERVED ARGININE-CAGE MOTIF IN THE GONADOTROPIN-RELEASING HORMONE RECEPTOR
J. Biol. Chem., April 24, 1998; 273(17): 10445 - 10453.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Kikkawa, M. Isogaya, T. Nagao, and H. Kurose
The Role of the Seventh Transmembrane Region in High Affinity Binding of a beta 2-Selective Agonist TA-2005
Mol. Pharmacol., January 1, 1998; 53(1): 128 - 134.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
L. B. Kozell and K. A. Neve
Constitutive Activity of a Chimeric D2/D1 Dopamine Receptor
Mol. Pharmacol., December 1, 1997; 52(6): 1137 - 1149.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
R. Grosse, T. Schöneberg, G. Schultz, and T. Gudermann
Inhibition of Gonadotropin-Releasing Hormone Receptor Signaling by Expression of a Splice Variant of the Human Receptor
Mol. Endocrinol., August 1, 1997; 11(9): 1305 - 1318.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. H. Perlman, A.-O. Colson, W. Wang, K. Bence, R. Osman, and M. C. Gershengorn
Interactions between Conserved Residues in Transmembrane Helices 1, 2, and 7 of the Thyrotropin-releasing Hormone Receptor
J. Biol. Chem., May 2, 1997; 272(18): 11937 - 11942.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. C. Sealfon, H. Weinstein, and R. P. Millar
Molecular Mechanisms of Ligand Interaction with the Gonadotropin-Releasing Hormone Receptor
Endocr. Rev., April 1, 1997; 18(2): 180 - 205.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
U. B. Kaiser, P. M. Conn, and W. W. Chin
Studies of Gonadotropin-Releasing Hormone (GnRH) Action Using GnRH Receptor-Expressing Pituitary Cell Lines
Endocr. Rev., February 1, 1997; 18(1): 46 - 70.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
L. Audoly and R. M. Breyer
Substitution of Charged Amino Acid Residues in Transmembrane Regions 6 and 7 Affect Ligand Binding and Signal Transduction of the Prostaglandin EP3 Receptor
Mol. Pharmacol., January 1, 1997; 51(1): 61 - 68.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-L. Parent, C. L. Gouill, E. Escher, and M. Rola-Pleszczynski
Identification of Transmembrane Domain Residues Determinant in the Structure-Function Relationship of the Human Platelet-activating Factor Receptor by Site-directed Mutagenesis
J. Biol. Chem., September 20, 1996; 271(38): 23298 - 23303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Davidson, C. A. McArdle, P. Davies, R. Elario, C. A. Flanagan, and R. P. Millar
Asn102 of the Gonadotropin-releasing Hormone Receptor Is a Critical Determinant of Potency for Agonists Containing C-terminal Glycinamide
J. Biol. Chem., June 28, 1996; 271(26): 15510 - 15514.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Gardella, M. D. Luck, M.-H. Fan, and C. Lee
Transmembrane Residues of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor That Specifically Affect Binding and Signaling by Agonist Ligands
J. Biol. Chem., May 31, 1996; 271(22): 12820 - 12825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Hwa, R. M. Graham, and D. M. Perez
Chimeras of alpha(1)-Adrenergic Receptor Subtypes Identify Critical Residues That Modulate Active State Isomerization
J. Biol. Chem., April 5, 1996; 271(14): 7956 - 7964.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Shire, B. Calandra, M. Delpech, X. Dumont, M. Kaghad, Gér. Le Fur, D. Caput, and P. Ferrara
Structural Features of the Central Cannabinoid CB1 Receptor Involved in the Binding of the Specific CB1 Antagonist SR 141716A
J. Biol. Chem., March 22, 1996; 271(12): 6941 - 6946.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. M. Fernandez and D. Puett
Lys[IMAGE] in the Third Extracellular Loop of the Lutropin/Choriogonadotropin Receptor Is Critical for Signaling
J. Biol. Chem., January 12, 1996; 271(2): 925 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Liu, T. Schöneberg, M. van Rhee, and Jür. Wess
Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors
J. Biol. Chem., August 18, 1995; 270(33): 19532 - 19539.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhou, V. Rodic, S. Kitanovic, C. A. Flanagan, L. Chi, H. Weinstein, S. Maayani, R. P. Millar, and S. C. Sealfon
A Locus of the Gonadotropin-releasing Hormone Receptor That Differentiates Agonist and Antagonist Binding Sites
J. Biol. Chem., August 11, 1995; 270(32): 18853 - 18857.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Lás. Hunyady, Már. Bor, A. J. Baukal, T.ás Balla, and K. J. Catt
A Conserved NPLFY Sequence Contributes to Agonist Binding and Signal Transduction but Is Not an Internalization Signal for the Type 1 Angiotensin II Receptor
J. Biol. Chem., July 14, 1995; 270(28): 16602 - 16609.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Sealfon, L. Chi, B. J. Ebersole, V. Rodic, D. Zhang, J. A. Ballesteros, and H. Weinstein
Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT[IMAGE] Receptor
J. Biol. Chem., July 14, 1995; 270(28): 16683 - 16688.
[Abstract] [Full Text] [PDF]